Asco 2025 · Posters · Cáncer de Mama · Federico Gustavo Rojo Todo Volver

TROP2 overexpression as predictor of outcome in patients with early triple-negative breast cancer. Exploratory analysis from the GEICAM_CIBOMA trial.

Abstract: 582
Poster Bd #: 175
Descargar Poster

Federico Gustavo Rojo Todo

Hospital Universitario Fundación Jiménez Díaz; CIBERONC-ISCCIII; GEICAM Spanish Breast Cancer Group

Una iniciativa científica de: Eco Logo
Clover sgm Logo
Con el patrocinio de: Regeneron Logo